Kato, T., Ono, H., Fujii, M., Akahoshi, K., Ogura, T., Ogawa, K., . . . Tanabe, M. (2021). Cytoplasmic RRM1 activation as an acute response to gemcitabine treatment is involved in drug resistance of pancreatic cancer cells. Public Library of Science (PLoS).
Chicago Style (17th ed.) CitationKato, Tomotaka, et al. Cytoplasmic RRM1 Activation as an Acute Response to Gemcitabine Treatment Is Involved in Drug Resistance of Pancreatic Cancer Cells. Public Library of Science (PLoS), 2021.
MLA (8th ed.) CitationKato, Tomotaka, et al. Cytoplasmic RRM1 Activation as an Acute Response to Gemcitabine Treatment Is Involved in Drug Resistance of Pancreatic Cancer Cells. Public Library of Science (PLoS), 2021.
Warning: These citations may not always be 100% accurate.